Author

JR Gralow

Observed institutions: University of North Carolina at Chapel Hill, Prisma Health, MedStar Washington Hospital Center, Dartmouth–Hitchcock Medical Center, BC Cancer Agency, Mount Sinai Hospital, Dalhousie University, Sanford Health, Sparrow Health System, Sunnybrook Health Science Centre, Mayo Clinic, Seattle Cancer Care Alliance, The University of Texas MD Anderson Cancer Center, University of Miami, The University of Texas at San Antonio Health Science Center, University of Pittsburgh, University of Alabama, University of California, San Francisco, Baylor College of Medicine, Genentech, University of Toronto, Loyola University Chicago, University of Washington, University of California, Irvine, Lunenfeld-Tanenbaum Research Institute, University of Michigan, Columbia University Irving Medical Center, Juravinski Cancer Centre, Leiden University Medical Center, Allegheny General Hospital, London Health Sciences Centre, Stony Brook University Hospital, Washington Hospital, Henry Ford Hospital, University of Alabama at Birmingham, Yale University, Fred Hutch Cancer Center, Sarah Cannon, Cancer Research And Biostatistics, Angeles Clinic and Research Institute, Magee-Womens Hospital, Dana-Farber Cancer Institute, Mayo Clinic in Arizona, UPMC Hillman Cancer Center, EvergreenHealth, Tennessee Oncology, Centre Hospitalier de l’Université de Montréal, Mayo Clinic in Florida, Bassett Medical Center, Loyola Medicine, Genomic Health (United States), SWOG Cancer Research Network, UCSF Helen Diller Family Comprehensive Cancer Center, Indiana University Indianapolis, Ottawa Hospital Research Institute, University of Arizona Cancer Center, UC Davis Comprehensive Cancer Center, Indiana University, Stony Brook University, University of Pennsylvania, University of Arkansas for Medical Sciences, McMaster University
OpenAlex ID: A5079737792
2011 · Rahber Thariani, Jonathan Carlson, et al. · University of Twente Research Information
Works count: 29
Citation count: 409
H-index: 6
I10-index: 5
Year
Topic
Type